Jade Biosciences (JBIO) Current Assets (2020 - 2026)
Jade Biosciences (JBIO) posted Current Assets of $318.5 million for Q1 2026, down 8.69% on a QoQ basis from $348.8 million in Q4 2025, and up 311.66% year-over-year from $77.4 million in Q1 2025.
Jade Biosciences (JBIO) Current Assets (2020 - 2026) Analysis & Trends
Jade Biosciences' Current Assets history runs 7 years deep, the most recent figure standing at $318.5 million for Q1 2026.
- Quarterly Current Assets rose 311.66% year-over-year to $318.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $318.5 million (up 311.66% YoY) and the FY2025 annual result came in at $348.8 million, up 400.78% from the prior year.
- Current Assets was $318.5 million for Q1 2026 at Jade Biosciences, down from $348.8 million in the prior quarter.
- Across five years, Current Assets topped out at $348.8 million in Q4 2025 and bottomed at $69.7 million in Q4 2024.
- A 5-year average of $157.3 million and a median of $137.6 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets sank 43.93% — and 2025, when it soared 400.78%.
- Jade Biosciences' Current Assets stood at $131.5 million in 2022, then slipped by 5.52% to $124.2 million in 2023, then sank by 43.93% to $69.7 million in 2024, then surged by 400.78% to $348.8 million in 2025, then fell by 8.69% to $318.5 million in 2026.
- Business Quant data shows JBIO's Current Assets at $318.5 million in Q1 2026, $348.8 million in Q4 2025, and $201.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 318.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318.52 Mn |
| Dec 31, 2025 | 348.82 Mn |
| Sep 30, 2025 | 201.36 Mn |
| Jun 30, 2025 | 222.98 Mn |
| Mar 31, 2025 | 77.37 Mn |
| Dec 31, 2024 | 69.65 Mn |
| Sep 30, 2024 | 90.61 Mn |
| Jun 30, 2024 | 110.76 Mn |
| Mar 31, 2024 | 103.24 Mn |
| Dec 31, 2023 | 124.23 Mn |
| Sep 30, 2023 | 137.60 Mn |
| Jun 30, 2023 | 152.47 Mn |
| Mar 31, 2023 | 120.57 Mn |
| Dec 31, 2022 | 131.50 Mn |
| Sep 30, 2022 | 145.16 Mn |
| Jun 30, 2022 | 153.45 Mn |
| Mar 31, 2022 | 165.89 Mn |
| Dec 31, 2021 | 174.33 Mn |
| Sep 30, 2021 | 183.10 Mn |
| Jun 30, 2021 | 59.31 Mn |